| 1 | K(D)PT | - | - | - | - | [1] 97 97 💬
|
| 2 | K-808 | - | - | - | - | [1] 93 93 💬
|
| 3 | K-808 (Dose A) | - | - | - | - | [1] 93 93 💬
|
| 4 | K-808 (Dose B) | - | - | - | - | [1] 93 93 💬
|
| 5 | K-832 | - | - | - | - | [1] 46 46 💬
|
| 6 | K0706 | - | - | - | - | [1] 6 6 💬
|
| 7 | Kaftrio | - | - | - | - | [1] 299 299 💬
|
| 8 | Kaletra (lopinavir [LPVr]) | [1] Lopinavir Lopinavir | [1] Lopinavir
Lopinavir
💬
| - | - | [1] 265 265 💬
|
| 9 | Kalydeco | - | - | - | - | [2] 299 299, 340 💬
|
| 10 | Kalydeco 150 mg film-c | - | - | - | - | [1] 299 299 💬
|
| 11 | Kalydeco 150 mg film-coated tablets | - | - | - | - | [1] 299 299 💬
|
| 12 | Kalydeco 150mg | - | - | - | - | [1] 299 299 💬
|
| 13 | Kamada -AAT for Inhalation or inhaled AAT (AAT) | - | - | - | - | [1] 231 231 💬
|
| 14 | Kamada -AAT for Inhalation or inhaled AAT (AAT)Pharmaceutical Form: Nebuliser solutionINN or Proposed INN: Alpha-1 Antitrypsin (AAT)CAS Number: 9041-92-3Current Sponsor code: Kamada-AATConcentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 20-Pharmaceutical form of the placebo: Nebuliser solutionRoute of administration of the placebo: Inhalation use | - | - | - | - | [1] 231 231 💬
|
| 15 | Kamada-AAT for inhalation | - | - | - | - | [1] 231 231 💬
|
| 16 | Kamada-AAT for Inhalation, 160mg | - | - | - | - | [1] 231 231 💬
|
| 17 | Kamada-AAT for Inhalation, 80mg | - | - | - | - | [1] 231 231 💬
|
| 18 | Kamada-API | - | - | - | - | [1] 231 231 💬
|
| 19 | Kamillenblüten 3ml/10ml | - | - | - | - | [1] 97 97 💬
|
| 20 | Kamlanoflast | - | - | - | - | [1] 2 2 💬
|
| 21 | Kanamycin | [1] Kanamycin Kanamycin | [2] Kanamycin sulfate
Kanamycin sulfate
,
Kanamycin sulfate
💬
| - | - | [2] 96 96, 291 💬
|
| 22 | KANUMA | - | - | - | - | [1] 19 19 💬
|
| 23 | Kappa (light chain) | - | - | - | - | [1] 61 61 💬
|
| 24 | Kappaproct | - | - | - | - | [1] 97 97 💬
|
| 25 | KAR5585 Capsules | - | - | - | - | [1] 86 86 💬
|
| 26 | Kardégic | - | - | - | - | [1] 63 63 💬
|
| 27 | Kasai Portoenterostomy | - | - | - | - | [1] 296 296 💬
|
| 28 | KB001 | [1] KB001 KB001 | - | - | - | [1] 299 299 💬
|
| 29 | KB001-A | [1] KB001 KB001 | - | - | - | [1] 299 299 💬
|
| 30 | KB003 | - | - | - | - | [1] 46 46 💬
|
| 31 | KB105 | - | - | - | - | [1] 160 160 💬
|
| 32 | KB195 | - | - | - | - | [1] 251 251 💬
|
| 33 | KB2115 | - | - | - | - | [1] 79 79 💬
|
| 34 | KB407 | [1] KB407 KB407 | - | - | - | [1] 299 299 💬
|
| 35 | KB407 (Nebulization) | [1] KB407 KB407 | - | - | - | [1] 299 299 💬
|
| 36 | KB408 (Nebulization) | - | - | - | - | [1] 231 231 💬
|
| 37 | KB803 | - | - | - | - | [1] 36 36 💬
|
| 38 | KBL697 | - | - | - | - | [1] 97 97 💬
|
| 39 | KC706 | [1] KC706 KC706 | - | - | - | [2] 35 35, 46 💬
|
| 40 | KCT-0809 ophthalmic solution | - | - | - | - | [1] 53 53 💬
|
| 41 | KD019 (tesevatinib) | [1] Tesevatinib Tesevatinib | [1] Tesevatinib
Tesevatinib
💬
| [5] EGFR EGFR, EPHB4, ERBB2, FLT4, KDR 💬
| [54] Adherens junction Adherens junction, Axon guidance, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease, Cushing syndrome, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Tight junction, VEGF signaling pathway, Virion - Hepatitis viruses 💬 | [1] 67 67 💬
|
| 42 | KD6005 | - | - | - | - | [1] 46 46 💬
|
| 43 | KdPT | - | - | - | - | [1] 97 97 💬
|
| 44 | KDT-3594 | [1] KDT-3594 KDT-3594 | - | - | - | [1] 6 6 💬
|
| 45 | Kedrion IVIG 10% | - | - | - | - | [2] 63 63, 65 💬
|
| 46 | Kemstro | - | - | - | - | [1] 13 13 💬
|
| 47 | KENACORT | - | - | - | - | [2] 90 90, 96 💬
|
| 48 | KENACORT - 40 MG/ ML SOSPENSIONE INIETTABILE 3 FLACONCINI DA 1 ML | - | - | - | - | [1] 90 90 💬
|
| 49 | Kenalog | - | - | - | - | [1] 46 46 💬
|
| 50 | Kenalog Injectable Product | - | - | - | - | [1] 70 70 💬
|
| 51 | Kepivance | - | - | - | - | [1] 13 13 💬
|
| 52 | KEPPRA | - | - | - | - | [1] 13 13 💬
|
| 53 | Keppra 250mg | - | - | - | - | [1] 13 13 💬
|
| 54 | Keppra 500mg | - | - | - | - | [1] 13 13 💬
|
| 55 | Keppra ® | - | - | - | - | [1] 13 13 💬
|
| 56 | Kera-X | - | - | - | - | [1] 168 168 💬
|
| 57 | Kesimpta | - | - | - | - | [1] 13 13 💬
|
| 58 | Kesimpta 20 mg Injektionslösung im Fertigpen | - | - | - | - | [1] 13 13 💬
|
| 59 | Kesimpta 20 mg solution for injection in pre-filled pen | - | - | - | - | [1] 13 13 💬
|
| 60 | KETAMINE | [1] Ketamine Ketamine | [2] Ketamine hydrochloride
Ketamine hydrochloride
,
Ketamine
💬
| [5] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| [21] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [6] 6 6, 13, 70, 113, 156, 215 💬
|
| 61 | Ketamine hydrochloride | [1] Ketamine Ketamine | [2] Ketamine hydrochloride
Ketamine hydrochloride
,
Ketamine
💬
| [5] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| [21] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 62 | Ketamine Infusion | [1] Ketamine Ketamine | [2] Ketamine hydrochloride
Ketamine hydrochloride
,
Ketamine
💬
| [5] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| [21] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 63 | Ketanest-S | - | - | - | - | [3] 2 2, 4, 70 💬
|
| 64 | KetoCal | - | - | - | - | [1] 2 2 💬
|
| 65 | Ketocal 4:1 liquid Nutricia (intervention) | - | - | - | - | [1] 256 256 💬
|
| 66 | Ketoconazole | [1] Ketoconazole Ketoconazole | [1] Ketoconazole
Ketoconazole
💬
| - | - | [3] 8 8, 13, 75 💬
|
| 67 | Ketoflo | - | - | - | - | [1] 248 248 💬
|
| 68 | Ketogenic Diet | - | - | - | - | [7] 13 13, 21, 49, 77, 127, 145, 148 💬
|
| 69 | Ketogenic medium chain triglyceride drink (MCT drink) | - | - | - | - | [1] 127 127 💬
|
| 70 | Ketone Diol, R-1,3-butanediol (Ketone-IQ) | - | - | - | - | [1] 67 67 💬
|
| 71 | Ketone ester | - | - | - | - | [1] 67 67 💬
|
| 72 | Ketone Ester (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate | - | - | - | - | [1] 6 6 💬
|
| 73 | Ketone Ester Beverage | - | - | - | - | [1] 6 6 💬
|
| 74 | Ketone ester drink | - | - | - | - | [2] 6 6, 344 💬
|
| 75 | Ketone Ester Elite endurance Nutrition Drink | - | - | - | - | [1] 6 6 💬
|
| 76 | Ketone Monoester | - | - | - | - | [1] 299 299 💬
|
| 77 | Ketone/Glucose Monitoring | - | - | - | - | [1] 67 67 💬
|
| 78 | Ketoprofen | [1] Ketoprofen Ketoprofen | [3] Ketoprofen
Ketoprofen
,
Ketoprofen lysine
,
Ketoprofen sodium
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [2] 13 13, 46 💬
|
| 79 | Ketorolac | [1] Ketorolac Ketorolac | [2] Ketorolac tromethamine
Ketorolac tromethamine
,
Ketorolac
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [2] 70 70, 226 💬
|
| 80 | Ketorolac Tromethamine | [2] Ketorolac Ketorolac, Tromethamine | [3] Tromethamine
Tromethamine
,
Ketorolac tromethamine
,
Ketorolac
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 226 226 💬
|
| 81 | Ketosteril | - | - | - | - | [1] 222 222 💬
|
| 82 | KEVZARA | - | - | - | - | [1] 46 46 💬
|
| 83 | Kevzara ® | - | - | - | - | [1] 41 41 💬
|
| 84 | Keyhole limpet hemocyanin | [1] Keyhole limpet hemocyanin Keyhole limpet hemocyanin | - | - | - | [2] 13 13, 46 💬
|
| 85 | Keyhole limpet hemocyanin (KLH) | [1] Keyhole limpet hemocyanin Keyhole limpet hemocyanin | - | - | - | [1] 13 13 💬
|
| 86 | Keyhole limpet hemocyanin (KLH) neo-antigen | [1] Keyhole limpet hemocyanin Keyhole limpet hemocyanin | - | - | - | [1] 13 13 💬
|
| 87 | Keyo | - | - | - | - | [1] 248 248 💬
|
| 88 | KH176 | [1] Sonlicromanol Sonlicromanol | - | - | - | [2] 21 21, 302 💬
|
| 89 | KHK4083 | - | - | - | - | [1] 97 97 💬
|
| 90 | KHK4827 | - | - | - | - | [2] 37 37, 51 💬
|
| 91 | KHK4827 140mg SC | - | - | - | - | [1] 37 37 💬
|
| 92 | KHK4827 210mg SC | - | - | - | - | [1] 37 37 💬
|
| 93 | Kidney Transplant | - | - | - | - | [2] 19 19, 222 💬
|
| 94 | KIg10 | - | - | - | - | [1] 65 65 💬
|
| 95 | KIN-1901 | - | - | - | - | [1] 271 271 💬
|
| 96 | KIN-1902 | - | - | - | - | [1] 84 84 💬
|
| 97 | KINE-101 | - | - | - | - | [1] 14 14 💬
|
| 98 | KINERET | - | - | - | - | [8] 41 41, 49, 54, 57, 65, 106, 266, 299 💬
|
| 99 | KINERET - 100 MG/0,67 ML SOLUZIONE INIETTABILE USO SOTTOCUTANEO SIRINGA PRERIEMPITA 7 SIRINGHE PRERIEMPITE | - | - | - | - | [1] 57 57 💬
|
| 100 | Kineret 100 mg injection | - | - | - | - | [1] 54 54 💬
|
| 101 | Kineret injection | - | - | - | - | [1] 54 54 💬
|
| 102 | KINERET*SC 7SIR 100MG 0,67ML | - | - | - | - | [4] 28 28, 46, 106, 107 💬
|
| 103 | Kineret® | - | - | - | - | [1] 46 46 💬
|
| 104 | Kineret® (Anakinra) | [1] Anakinra Anakinra | [1] Anakinra
Anakinra
💬
| [2] IL1R1 IL1R1, IL1R2 💬
| [15] Amoebiasis Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | [1] 46 46 💬
|
| 105 | Kineret® or anakinra | [1] Anakinra Anakinra | [1] Anakinra
Anakinra
💬
| [2] IL1R1 IL1R1, IL1R2 💬
| [15] Amoebiasis Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | [1] 107 107 💬
|
| 106 | Kinetra and Soletra (neurostimulator, Medtronic) | - | - | - | - | [1] 6 6 💬
|
| 107 | Kinoquinone (proposed) | - | - | - | - | [1] 6 6 💬
|
| 108 | KIO-301 | [1] KIO-301 KIO-301 | - | - | - | [1] 90 90 💬
|
| 109 | KIOVIG | - | - | - | - | [2] 14 14, 65 💬
|
| 110 | KIOVIG - 100 MG/ML SOLUZIONE PER INFUSIONE USO INTRAVENOSO FLACONE VETRO 1 G/10 ML 1 FLACONE | - | - | - | - | [1] 14 14 💬
|
| 111 | KIOVIG 100 mg/ml solution for infusion | - | - | - | - | [2] 14 14, 65 💬
|
| 112 | Kirunal Fish Oil | [1] Fish oil Fish oil | - | - | - | [1] 13 13 💬
|
| 113 | Kisspeptin | [1] Kisspeptin Kisspeptin | - | - | - | [1] 74 74 💬
|
| 114 | Kisspeptin 112-121 | [1] Kisspeptin Kisspeptin | - | - | - | [1] 74 74 💬
|
| 115 | KIT2014 | - | - | - | - | [1] 299 299 💬
|
| 116 | KITE-363 | - | - | - | - | [5] 11 11, 13, 14, 49, 51 💬
|
| 117 | KJ103 for Injection | - | - | - | - | [1] 221 221 💬
|
| 118 | KJX839 | - | - | - | - | [1] 79 79 💬
|
| 119 | KK4277 | - | - | - | - | [1] 49 49 💬
|
| 120 | KK8398 | - | - | - | - | [1] 276 276 💬
|
| 121 | KL1333 | [1] KL1333 KL1333 | - | - | - | [1] 21 21 💬
|
| 122 | KL1333 100 mg | [1] KL1333 KL1333 | - | - | - | [1] 21 21 💬
|
| 123 | KL1333 200 mg | [1] KL1333 KL1333 | - | - | - | [1] 21 21 💬
|
| 124 | KL1333 25 mg | [1] KL1333 KL1333 | - | - | - | [1] 21 21 💬
|
| 125 | KL1333 400 mg | [1] KL1333 KL1333 | - | - | - | [1] 21 21 💬
|
| 126 | KL1333 50 mg | [1] KL1333 KL1333 | - | - | - | [1] 21 21 💬
|
| 127 | KL1333 600 mg | [1] KL1333 KL1333 | - | - | - | [1] 21 21 💬
|
| 128 | KL1333 800 mg | [1] KL1333 KL1333 | - | - | - | [1] 21 21 💬
|
| 129 | Klacid | - | - | - | - | [1] 299 299 💬
|
| 130 | KLEAN PREP - POLVERE PER SOLUZIONE ORALE 4 BUSTINE DA 69 G | - | - | - | - | [1] 97 97 💬
|
| 131 | KLEAN-PREP | - | - | - | - | [1] 97 97 💬
|
| 132 | KleanLyte | - | - | - | - | [2] 96 96, 97 💬
|
| 133 | KLH | - | - | - | - | [2] 13 13, 65 💬
|
| 134 | KM-819 | - | - | - | - | [2] 6 6, 17 💬
|
| 135 | KN019, 10 mg/kg | - | - | - | - | [1] 46 46 💬
|
| 136 | KN019, 5mg/kg | - | - | - | - | [1] 46 46 💬
|
| 137 | KN5501 cell injection | - | - | - | - | [1] 49 49 💬
|
| 138 | KN5601 | - | - | - | - | [1] 49 49 💬
|
| 139 | KNS-760704 | - | - | - | - | [1] 2 2 💬
|
| 140 | Korean Red Ginseng | [1] Ginseng Ginseng | [2] Red ginseng
Red ginseng
,
Ginseng
💬
| - | - | [1] 53 53 💬
|
| 141 | Koru 24 G HIgH Flo Subcutaneous Safety Needle Set (investigational in the US) | - | - | - | - | [1] 65 65 💬
|
| 142 | Koselugo 10mg | - | - | - | - | [1] 34 34 💬
|
| 143 | Koselugo 25mg | - | - | - | - | [1] 34 34 💬
|
| 144 | KP-001 | - | - | - | - | [3] 278 278, 279, 281 💬
|
| 145 | KP-2541 | - | - | - | - | [1] 28 28 💬
|
| 146 | KP104 | - | - | - | - | [4] 49 49, 62, 66, 223 💬
|
| 147 | KP405 | - | - | - | - | [1] 6 6 💬
|
| 148 | KPG-818 | - | - | - | - | [1] 49 49 💬
|
| 149 | KPG-818 high dose | - | - | - | - | [1] 49 49 💬
|
| 150 | KPG-818 low dose | - | - | - | - | [1] 49 49 💬
|
| 151 | KPG-818 mid dose | - | - | - | - | [1] 49 49 💬
|
| 152 | KPL-301 | - | - | - | - | [1] 41 41 💬
|
| 153 | KPL-404 | - | - | - | - | [1] 46 46 💬
|
| 154 | KPS-0373 | - | - | - | - | [1] 18 18 💬
|
| 155 | KPS-0373, High dose | - | - | - | - | [1] 18 18 💬
|
| 156 | KPS-0373, Low dose | - | - | - | - | [1] 18 18 💬
|
| 157 | KQ-2003 CAR T-cells | - | - | - | - | [1] 16 16 💬
|
| 158 | KR002524 | - | - | - | - | [1] 46 46 💬
|
| 159 | Kremezin | - | - | - | - | [2] 96 96, 97 💬
|
| 160 | Kremezin®, Spherical Adsorptive Carbon | - | - | - | - | [2] 96 96, 97 💬
|
| 161 | Kreon 25 000 | - | - | - | - | [1] 299 299 💬
|
| 162 | Kreon 25,000 Units | - | - | - | - | [1] 299 299 💬
|
| 163 | Kreon 25000 | - | - | - | - | [2] 298 298, 299 💬
|
| 164 | KREON de Liberación Inmediata | - | - | - | - | [1] 299 299 💬
|
| 165 | KREON N 25000 | - | - | - | - | [1] 299 299 💬
|
| 166 | Kreon® 25,000 | - | - | - | - | [1] 299 299 💬
|
| 167 | Krill oil | [1] Krill oil Krill oil | - | - | - | [1] 79 79 💬
|
| 168 | Krio | - | - | - | - | [1] 248 248 💬
|
| 169 | KRN23 | - | - | - | - | [1] 238 238 💬
|
| 170 | KRP-R120 | - | - | - | - | [1] 84 84 💬
|
| 171 | KRP203 | - | - | - | - | [1] 97 97 💬
|
| 172 | KRP203A | - | - | - | - | [1] 97 97 💬
|
| 173 | KRRO-110 | - | - | - | - | [1] 231 231 💬
|
| 174 | KSP-0243 | - | - | - | - | [1] 97 97 💬
|
| 175 | KSVCBD injection | - | - | - | - | [1] 13 13 💬
|
| 176 | KT501 | - | - | - | - | [1] 46 46 💬
|
| 177 | KT502 | - | - | - | - | [1] 46 46 💬
|
| 178 | Kunxian Capsule | - | - | - | - | [2] 46 46, 271 💬
|
| 179 | KUVAN | - | - | - | - | [1] 240 240 💬
|
| 180 | Kuvan 100mg soluble tablet | - | - | - | - | [1] 240 240 💬
|
| 181 | KuvanTM Therapy | - | - | - | - | [1] 240 240 💬
|
| 182 | Kuvan® | - | - | - | - | [1] 240 240 💬
|
| 183 | Kuvan® (sapropterin dihydrochloride) | [1] Sapropterin Sapropterin | [2] Sapropterin dihydrochloride
Sapropterin dihydrochloride
,
Sapropterin
💬
| - | - | [1] 240 240 💬
|
| 184 | KVD824 | - | - | - | - | [1] 65 65 💬
|
| 185 | KVD824 300 mg Compresse a rilascio modificato | - | - | - | - | [1] 65 65 💬
|
| 186 | KVD824 300 mg Modified Release Tablets | - | - | - | - | [1] 65 65 💬
|
| 187 | KVD824 hydrochloride | - | - | - | - | [1] 65 65 💬
|
| 188 | KVD824 Immediate-Release Capsule | - | - | - | - | [1] 65 65 💬
|
| 189 | KVD824 Prototype 1 modified-release tablet | - | - | - | - | [1] 65 65 💬
|
| 190 | KVD824 Prototype 2 modified-release tablet | - | - | - | - | [1] 65 65 💬
|
| 191 | KVD824 Prototype 3 modified-release tablet | - | - | - | - | [1] 65 65 💬
|
| 192 | KVD900 | - | - | - | - | [1] 65 65 💬
|
| 193 | KVD900 100 mg Film Coated Tablet | - | - | - | - | [1] 65 65 💬
|
| 194 | KVD900 150 mg | - | - | - | - | [1] 65 65 💬
|
| 195 | KVD900 300 mg | - | - | - | - | [1] 65 65 💬
|
| 196 | KVD900 300 mg compressa rivestita con film | - | - | - | - | [1] 65 65 💬
|
| 197 | KVD900 300 mg Film Coated Tablet | - | - | - | - | [1] 65 65 💬
|
| 198 | KVD900 600 mg | - | - | - | - | [1] 65 65 💬
|
| 199 | KW-0761 0.3 mg/kg IV | - | - | - | - | [1] 26 26 💬
|
| 200 | KW-6002 | - | - | - | - | [1] 6 6 💬
|
| 201 | KW-6002 (istradefylline) | [1] Istradefylline Istradefylline | [1] Istradefylline
Istradefylline
💬
| [1] ADORA2A ADORA2A 💬
| [8] Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 202 | KW-6356 | [1] KW-6356 KW-6356 | - | - | - | [1] 6 6 💬
|
| 203 | KW-6356 High Dose | [1] KW-6356 KW-6356 | - | - | - | [1] 6 6 💬
|
| 204 | KW-6356 Low Dose | [1] KW-6356 KW-6356 | - | - | - | [1] 6 6 💬
|
| 205 | KW-6356 Middle Dose | [1] KW-6356 KW-6356 | - | - | - | [1] 6 6 💬
|
| 206 | KW-6356 X Dose | [1] KW-6356 KW-6356 | - | - | - | [1] 6 6 💬
|
| 207 | KW-6356 Y Dose | [1] KW-6356 KW-6356 | - | - | - | [1] 6 6 💬
|
| 208 | KW-6500 | - | - | - | - | [1] 6 6 💬
|
| 209 | Kybella | - | - | - | - | [1] 34 34 💬
|
| 210 | Kynamro | - | - | - | - | [1] 79 79 💬
|
| 211 | Kyo-Dophilus | - | - | - | - | [1] 97 97 💬
|
| 212 | KYV-101 | [1] KYV-101 KYV-101 | - | - | - | [5] 11 11, 13, 46, 50, 51 💬
|
| 213 | KYV-101 (Biological) - 0.33 ×10^8 cells | [1] KYV-101 KYV-101 | - | - | - | [1] 13 13 💬
|
| 214 | KYV-101 (Biological) - 1 ×10^8 cells | [1] KYV-101 KYV-101 | - | - | - | [1] 13 13 💬
|
| 215 | KYV-101 anti-CD19 CAR-T cell therapy | [1] KYV-101 KYV-101 | - | - | - | [1] 13 13 💬
|
| 216 | KYV101 | - | - | - | - | [1] 46 46 💬
|
| 217 | KZR-616 | - | - | - | - | [4] 49 49, 50, 61, 63 💬
|
| 218 | KZR-616 maleate | - | - | - | - | [1] 50 50 💬
|
| 219 | Kümmel 2ml/10ml | - | - | - | - | [1] 97 97 💬
|